Peptistar has integrated Asahi Kasei’s novel forward osmosis–membrane distillation (FO–MD) system into its facility for trial production of APIs.

The U.S. Veterinary API Manufacturing Market was valued at USD 2.02 Billion in 2025 and is projected to reach USD 4.84 Billion by 2035, while Europe is expected to grow from USD 2.02 Billion to USD 4.

Manufacturers and contract development and manufacturing organizations are developing processes and facilities to meet growing specialty API demand. For decades, APIs, the foundation of the ...

Industry urges govt to tap idle API manufacturing capacity to avoid costly duplication: Shardul Nautiyal, Mumbai Monday, June 22, 2026, 08:00 Hrs [IST] Industry associations have ...

Therapiva, a joint venture of Abu Dhabi-based Neopharma and India’s Laxai Life Sciences, says it has a GMP manufacturing plant in India. It will now add Dr. Reddy's entire API manufacturing business. ...

Manufacturers in Europe and the United States have announced plans for new in-country API development and manufacturing capabilities. Manufacturers in Europe and the United States have announced plans ...

Almost half of all FDA warnings letters since early 2018 were sent to Indian and Chinese plants, according to a report. (FDA) () China and India, which are the largest producers of APIs for the U.S.

Efficiency and adaptability are crucial in the ever-evolving manufacturing industry. As manufacturers adopt advanced technologies like IoT, AI, and cloud computing, the need for seamless integration ...